prof. dr. T.P. Links

No picture available
E-mail:
t.p.links umcg.nl

Research

  1. 2020
  2. van Santen, H. M., Alexander, E. K., Rivkees, S. A., Frey, E., Clement, S. C., Dierselhuis, M. P., ... Verburg, F. (2020). Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors. European Journal of Endocrinology, 183(3), P1-P10. https://doi.org/10.1530/EJE-20-0237
  3. Flinterman, L. E., Kuiper, J. G., Korevaar, J. C., van Dijk, L., Hek, K., Houben, E., ... Fliers, E. (2020). Impact of a Forced Dose-Equivalent Levothyroxine Brand Switch on Plasma Thyrotropin: A Cohort Study. Thyroid. https://doi.org/10.1089/thy.2019.0414
  4. 2019
  5. van der Tuin, K., Garcia, M. V., Corver, W. E., Khalifa, M. N., Neto, D. R., Corssmit, E. P. M., ... Morreau, H. (2019). Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma. European Journal of Endocrinology, 180(4), 235-241. https://doi.org/10.1530/EJE-18-0653
  6. 2018
  7. de Vries, L. H., Lodewijk, L., Willems, S. M., Dreijerink, K. M. A., de Keizer, B., van Diest, P. J., ... Vriens, M. R. (2018). SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival. Endocrine, 62(3), 639-647. https://doi.org/10.1007/s12020-018-1706-1
  8. Lodewijk, L., Willems, S. M., Dreijerink, K. M. A., de Keizer, B., van Diest, P. J., Schepers, A., ... Vriens, M. R. (2018). The theranostic target prostate-specific membrane antigen is expressed in medullary thyroid cancer. Human Pathology, 81, 245-254. https://doi.org/10.1016/j.humpath.2018.06.035
  9. Krauss, T., Ferrara, A. M., Links, T. P., Wellner, U., Bancoss, I., Kvachenyuk, A., ... Daerr, R. (2018). Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors. Endocrine-Related cancer, 25(9), 783-793. https://doi.org/10.1530/ERC-18-0100
  10. Neumann, H. P., Young, W. F., Krauss, T., Bayley, J-P., Schiavi, F., Opocher, G., ... Eng, C. (2018). 65 YEARS OF THE DOUBLE HELIX Genetics informs precision practice in the diagnosis and management of pheochromocytoma. Endocrine-Related cancer, 25(8), T201-T219. https://doi.org/10.1530/ERC-18-0085
  11. Eijkelenkamp, K., Olderode-Berends, M. J. W., van der Luijt, R. B., Robledo, M., van Dooren, M., Feelders, R. A., ... van der Horst-Schrivers, A. N. A. (2018). Homozygous TMEM127 mutations in 2 patients with bilateral pheochromocytomas. Clinical Genetics, 93(5), 1049-1056. https://doi.org/10.1111/cge.13202
  12. Stunnenberg, B. C., Raaphorst, J., Deenen, J. C. W., Links, T. P., Wilde, A. A., Verbove, D. J., ... Ginjaar, H. B. (2018). Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands. Neuromuscular disorders, 28(5), 402-407. https://doi.org/10.1016/j.nmd.2018.03.006
  13. 2017
Previous 1 2 3 4 5 6 7 Next

ID: 181494